AccuImage qualifies for Over-the-Counter tradingThe OTC Bulletin Board has authorized AccuImage Diagnostics to begin trading its stock on the OTCBB under "AIDP" as of Oct. 23. The San Francisco-based imaging company counts year-to-date income
AccuImage qualifies for Over-the-Counter trading
The OTC Bulletin Board has authorized AccuImage Diagnostics to begin trading its stock on the OTCBB under "AIDP" as of Oct. 23. The San Francisco-based imaging company counts year-to-date income of $252,096 and revenue of $2.3 million and claims that its revenue has more than doubled over the same period in 1999. AccuImage develops three-dimensional visualization software, including products that enable 3-D Web-based PACS review, and digital image distribution and archiving technologies. The company is actively pursuing strategic alliances with equipment vendors and broadband providers.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.